Cargando…
Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981516/ http://dx.doi.org/10.1186/1745-6215-14-S1-O120 |
| _version_ | 1782311060533936128 |
|---|---|
| author | Gregory, Walter Marshall, Helen Cameron, David Twelves, Christopher Bell, Richard Coleman, Robert |
| author_facet | Gregory, Walter Marshall, Helen Cameron, David Twelves, Christopher Bell, Richard Coleman, Robert |
| author_sort | Gregory, Walter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3981516 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39815162014-04-24 Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer Gregory, Walter Marshall, Helen Cameron, David Twelves, Christopher Bell, Richard Coleman, Robert Trials Oral Presentation BioMed Central 2013-11-29 /pmc/articles/PMC3981516/ http://dx.doi.org/10.1186/1745-6215-14-S1-O120 Text en Copyright © 2013 Gregory et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation Gregory, Walter Marshall, Helen Cameron, David Twelves, Christopher Bell, Richard Coleman, Robert Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title | Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title_full | Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title_fullStr | Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title_full_unstemmed | Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title_short | Modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| title_sort | modelling residual disease volume and re-growth rates from response durations to aid in cancer trial design, interpretation and analysis, with a particular focus on breast cancer |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981516/ http://dx.doi.org/10.1186/1745-6215-14-S1-O120 |
| work_keys_str_mv | AT gregorywalter modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer AT marshallhelen modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer AT camerondavid modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer AT twelveschristopher modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer AT bellrichard modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer AT colemanrobert modellingresidualdiseasevolumeandregrowthratesfromresponsedurationstoaidincancertrialdesigninterpretationandanalysiswithaparticularfocusonbreastcancer |